EU Investigates Data Use by X´s AI Chatbot

The European Union launches a probe into Elon Musk´s platform X regarding the use of personal data for Artificial Intelligence training.

Ireland´s Data Protection Commission (DPC), representing the European Union, has initiated an inquiry into the usage of personal data by Elon Musk´s social media platform X. This data is allegedly being utilized to train X´s Artificial Intelligence chatbot, Grok. The DPC is investigating the processing of personal data, specifically focusing on the posts available on the X platform which are publicly accessible across the EU.

The investigation aims to determine whether the handling of this personal data complies with the legal framework, especially concerning the training of Grok´s Large Language Models (LLMs). Last year, the DPC initiated a court case against X for violating data privacy laws, arguing that the platform´s usage of EU users´ public posts for Artificial Intelligence training breached rights and regulations. As X headquarters are in Ireland, the DPC is the primary authority overseeing its activities in Europe.

After X initially agreed to halt using this data, prompting the DPC to withdraw its case, developments in the platform´s Artificial Intelligence models have continued. The investigation now focuses on X´s adherence to the EU´s General Data Protection Regulation (GDPR), ensuring data processing´s lawfulness and transparency. The DPC´s move underscores the ongoing concern over privacy and data protection in Artificial Intelligence advancements.

56

Impact Score

Nvidia prepares PC return with Arm and x86 chip collaborations

Nvidia is preparing a return to the consumer PC market through new system-on-a-chip designs built with MediaTek Arm processors and separate x86 efforts tied to Intel, creating a potentially complex, dual-track strategy for Windows devices.

India’s role in pharma’s shift to Artificial Intelligence led platform models

Global pharma is moving from linear drug development to Artificial Intelligence led, platform-based models that tightly integrate discovery, data and manufacturing, opening a strategic window for India to move beyond cost-led scale. India’s opportunity lies in building integrated biopharma systems where science, digital intelligence and modular manufacturing are orchestrated from the outset.

Contact Us

Got questions? Use the form to contact us.

Contact Form

Clicking next sends a verification code to your email. After verifying, you can enter your message.